Hypertension After Pediatric Heart Transplantation is Primarily Associated With Immunosuppressive Regimen

Journal of Heart and Lung Transplantation

Volumn 27, Issue 5, 2008, Pages 501-507

  Roche, Susan L ^a   Kaufmann, Jacob ^a   Dipchand, Anne I ^a   Kantor, Paul F ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 42649144766     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.01.018     Document Type: Article

References (20)

1. Boucek M., Waltz D., Edwards L., et al. Registry of the International Society for Heart and Lung Transplantation: Ninth official pediatric heart transplant report-2006. J Heart Lung Transplant 25 (2006) 893-903
2. Thompson M., Shapiro A., Johnsen A., et al. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol 11 (1986) 219-229
3. Crespo-Leorp M. Arterial Hypertension. Transplant Proc 34 (2002) 127-129
4. Lindenfeld J., Page R., Zolty R., et al. Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation 111 (2005) 113-117
5. Reeves R.A., Shapiro A.P., Thompson M.E., and Johnsen A.M. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 73 (1986) 401-408
6. O'Sullivan J.J., Derrick G., and Gray J. Blood pressure after cardiac transplantation in Childhood. J Heart Lung Transplant 24 (2005) 891-895
7. Walker A., Locke T., Braidley P., and Al-Mohammed A. The importance of 24 hour ambulatory blood pressure monitoring after thoracic organ transplantation. J Heart Lung Transplant 24 (2005) 1770-1773
8. Taylor D., Barr M., Radovancevic B., et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18 (1999) 336-345
9. Radermacher J., Meiners M., Bramlage C., et al. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 11 (1998) 3-10
10. Lobac N., Pollock-Bar-Ziv S., West L., and Dipchand A. Sirolimus immunosuppression in pediatric heart transplant recipients: a single centre experience. J Heart Lung Transplant 24 (2005) 184-189
11. Soergel M., Kirschtein M., Busch C., et al. Oscillmetric twenty-four-hour blood pressure values in healthy children and adolescents: A multicentre trial including 1141 subjects. J Pediatr 130 (1997) 178-184
12. Schwartz G.J., Brion L.P., and Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clini North Am 34 (1987) 571-59
13. Ohkubo T., Hozawa A., Yamaguchi J., Kirkuya M., et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20 (2002) 2183-2189
14. Van Der Borne P., Leeman M., and Degaute J. Long-term and short-term blood pressure variability in transplanted patients. Ann N Y Acad Sci 783 (1996) 222-226
15. Imai Y., Abe K., Sasaki S., et al. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 12 (1988) 11-19
16. Murali S., Uretsky B., Reddy S., Griffith B., Hardesty R., and Trento A. Hemodynamic abnormalities following cardiac transplantation: Relationship to hypertension and survival. Am Heart J 118 (1989) 334-341
17. Eisen H., Tuzcu E., Dorent R., et al. Everolimus for the prevention of Allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 349 (2003) 847-858
18. Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110 (2004) 2694-2700
19. Ross M., Kouretas P., Gamberg P., et al. Ten- and 20-year survivors of pediatric orthotopic heart transplantation. J Heart Lung Transplant 25 (2006) 261-270
20. Rockx M., and Haddad H. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation. Curr Opin Cardiol 22 (2007) 128-132